BALAXI PHARMACEUTICALS LIMITED (BALAXI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, BALAXI PHARMACEUTICALS LIMITED (BALAXI) has a cash flow conversion efficiency ratio of 0.063x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs149.66 Million ≈ $1.62 Million USD) by net assets (Rs2.38 Billion ≈ $25.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see BALAXI PHARMACEUTICALS LIMITED (BALAXI) market capitalisation for the company's overall valuation and market capitalisation.
BALAXI PHARMACEUTICALS LIMITED - Cash Flow Conversion Efficiency Trend (2013–2026)
This chart illustrates how BALAXI PHARMACEUTICALS LIMITED's cash flow conversion efficiency has evolved over time, based on yearly financial data.
BALAXI PHARMACEUTICALS LIMITED Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BALAXI PHARMACEUTICALS LIMITED ranked by their cash flow conversion efficiency. Explore BALAXI PHARMACEUTICALS LIMITED cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Serstech AB
ST:SERT
|
-0.135x |
|
INOVIQ LTD.
F:EGQ0
|
N/A |
|
ERSU Meyve ve Gida Sanayi AS
IS:ERSU
|
-0.010x |
|
Artroniq Berhad
KLSE:0038
|
0.001x |
|
MYMBN Berhad
KLSE:0280
|
0.000x |
|
PIMS Inc.
KQ:347770
|
0.011x |
|
MMS Ventures Bhd
KLSE:0113
|
-0.026x |
|
Akritas S.A
AT:AKRIT
|
-0.137x |
Annual Cash Flow Conversion Efficiency for BALAXI PHARMACEUTICALS LIMITED (2013–2026)
The table below shows the annual cash flow conversion efficiency of BALAXI PHARMACEUTICALS LIMITED from 2013 to 2026. View BALAXI PHARMACEUTICALS LIMITED stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs2.49 Billion ≈ $26.94 Million |
Rs-82.44 Million ≈ $-891.57K |
-0.033x | +79.70% |
| 2025-03-31 | Rs2.32 Billion ≈ $25.06 Million |
Rs-377.82 Million ≈ $-4.09 Million |
-0.163x | -774.66% |
| 2024-03-31 | Rs2.01 Billion ≈ $21.78 Million |
Rs48.66 Million ≈ $526.25K |
0.024x | -27.26% |
| 2023-03-31 | Rs1.83 Billion ≈ $19.78 Million |
Rs60.75 Million ≈ $657.02K |
0.033x | -88.99% |
| 2022-03-31 | Rs1.13 Billion ≈ $12.24 Million |
Rs341.44 Million ≈ $3.69 Million |
0.302x | +632353.73% |
| 2021-03-31 | Rs649.80 Million ≈ $7.03 Million |
Rs31.00K ≈ $335.25 |
0.000x | +100.01% |
| 2020-03-31 | Rs277.46 Million ≈ $3.00 Million |
Rs-140.62 Million ≈ $-1.52 Million |
-0.507x | -18.39% |
| 2019-03-31 | Rs35.21 Million ≈ $380.73K |
Rs-15.07 Million ≈ $-162.98K |
-0.428x | +1.89% |
| 2018-03-31 | Rs15.55 Million ≈ $168.13K |
Rs-6.78 Million ≈ $-73.35K |
-0.436x | -3.84% |
| 2017-03-31 | Rs23.59 Million ≈ $255.13K |
Rs-9.91 Million ≈ $-107.20K |
-0.420x | +88.57% |
| 2016-03-31 | Rs314.87K ≈ $3.41K |
Rs-1.16 Million ≈ $-12.52K |
-3.676x | -156.12% |
| 2015-03-31 | Rs322.45K ≈ $3.49K |
Rs2.11 Million ≈ $22.84K |
6.551x | +2233.63% |
| 2014-03-31 | Rs7.80 Million ≈ $84.33K |
Rs-2.39 Million ≈ $-25.89K |
-0.307x | -171.16% |
| 2013-03-31 | Rs7.52 Million ≈ $81.34K |
Rs3.25 Million ≈ $35.09K |
0.431x | -- |
About BALAXI PHARMACEUTICALS LIMITED
Balaxi Pharmaceuticals Limited engages in the international wholesale distribution of pharmaceuticals, builders hardware, and FMCG products in India, Africa, and Latin America. The company offers pharmaceutical products across various therapeutic areas, including antibiotics, analgesic, anti-malaria, and others. It also provides biscuits and toothpaste. The company was formerly known as Balaxi Ve… Read more